DYSLIPIDAEMIA
Clinical trials for DYSLIPIDAEMIA explained in plain language.
Never miss a new study
Get alerted when new DYSLIPIDAEMIA trials appear
Sign up with your email to follow new studies for DYSLIPIDAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill combo aims to crush bad cholesterol
Disease control OngoingThis study tests whether adding a new drug called AZD0780 to the common statin rosuvastatin can lower 'bad' LDL cholesterol more than rosuvastatin alone. About 76 adults with high cholesterol will take either AZD0780 or a placebo pill, plus rosuvastatin, for 12 weeks. Neither par…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill could help control high cholesterol – study underway
Disease control OngoingThis study tests an experimental oral drug called AZD0780 in 432 adults with high LDL cholesterol (dyslipidaemia). Participants take the drug or a placebo daily for up to 52 weeks to see if it safely lowers cholesterol. The goal is to manage the condition, not cure it, as ongoing…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE2, PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Diet or drugs? new study tests if fasting beats pills for fatty liver disease
Disease control ENROLLING_BY_INVITATIONThis study tests whether a Mediterranean diet combined with intermittent fasting can reduce liver scarring (fibrosis) better than the weight-loss medication naltrexone/bupropion. About 70 adults with overweight or obesity and heart or metabolic risks (like type 2 diabetes or high…
Matched conditions: DYSLIPIDAEMIA
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC